Stay updated on Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page.

Latest updates to the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page
- CheckyesterdayChange DetectedMedlinePlus Genetics is now listed in related topics, alongside Melanoma.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check23 days agoChange DetectedRevision indicator updated to v3.4.3; references to Melanoma, MedlinePlus Genetics, and Revision: v3.4.2 were removed.SummaryDifference0.2%

- Check30 days agoChange DetectedAdded related topics: Melanoma and MedlinePlus Genetics to the study page.SummaryDifference0.2%

- Check51 days agoChange DetectedRevision: v3.4.2 was added, and the page removed the funding-status notice, Melanoma topic, related topics, and the prior Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check58 days agoChange DetectedAdded a site-wide notice about government funding impact and operational status; updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page.